Affordable Insulin for the COVID–19 Emergency Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 23, 2021)
Affordable Insulin for the COVID-19 Emergency Act
This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.
What just happenedMar 24, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 23, 2021
- Mar 24, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 23, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 23, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Mar 23, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Mar 23, 2021IntroReferralIntro-H
Introduced in House
- Mar 23, 2021IntroReferral1000
Introduced in House